BackgroundCheck.run
Search For

Dean Q Le, 41Stoughton, MA

Dean Le Phones & Addresses

Stoughton, MA   

Brockton, MA   

Randolph, MA   

Dedham, MA   

Mentions for Dean Q Le

Career records & work history

Medicine Doctors

Dean A. Le

Specialties:
Neurology
Work:
Saddleback Valley NeurosciencSaddleback Valley Neuroscience
24012 Calle De Ln Plata STE 150, Laguna Hills, CA 92653
949-8371130 (phone) 949-5871022 (fax)
Site
Education:
Medical School
Stanford University School of Medicine
Graduated: 1993
Procedures:
Lumbar Puncture, Sleep and EEG Testing
Conditions:
Alzheimer's Disease, Bell's Palsy, Carpel Tunnel Syndrome, Hemorrhagic stroke, Intracranial Injury, Ischemic Stroke, Migraine Headache, Multiple Sclerosis (MS), Myasthenia Gravis (MG), Transient Cerebral Ischemia, Dementia, Diabetic Peripheral Neuropathy, Epilepsy, Insomnia, Obstructive Sleep Apnea, Parkinson's Disease, Peripheral Nerve Disorders, Restless Leg Syndrome, Tension Headache
Languages:
English
Description:
Dr. Le graduated from the Stanford University School of Medicine in 1993. He works in Laguna Hills, CA and specializes in Neurology. Dr. Le is affiliated with Saddleback Memorial Medical Center.

Dean Le resumes & CV records

Resumes

Dean Le Photo 30

Dean Le

Dean Le Photo 31

Dean Le

Dean Le Photo 32

Nail Technician

Work:
Xpression Salon
Nail Technician
Dean Le Photo 33

Dean Le

Dean Le Photo 34

Dean Le

Publications & IP owners

Us Patents

Method Of Treating Cytotoxic Damage

US Patent:
6503947, Jan 7, 2003
Filed:
Jan 27, 1999
Appl. No.:
09/239056
Inventors:
Stuart A. Lipton - Newton MA
Dean Le - Cambridge MA
Marcus Kaul - Boston MA
Jonathan S. Stamler - Chapel Hill NC
Assignee:
Brigham and Womens Hospital - Boston MA
International Classification:
A61K 3115
US Classification:
514575
Abstract:
The invention features methods of treating cytotoxic damage in a subject comprising administering to the subject a substance which is a complement inhibitor, free radical scavenger, or both, to thereby treat cytotoxic damage. The methods of the invention can be used to treat cytotoxic damage associated with a non-thrombotic or thrombotic condition. Methods of treating thrombotic conditions such as stroke and/or ischemia in a subject, comprise administering a thrombolytic agent and a substance which is a complement inhibitor, free radical scavenger or both.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.